Attleboro, MA, United States of America

John C Arruda

This inventor holds 1 USPTO granted patent. Top assignee: Chiron Diagnostics Corporation. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John C Arruda: Innovator in Nucleic Acid Detection

Introduction

John C Arruda is a notable inventor based in Attleboro, MA (US). He has made significant contributions to the field of molecular biology, particularly in the detection of specific nucleic acids. His innovative approach has the potential to enhance the accuracy and efficiency of gene probe assays.

Latest Patents

John C Arruda holds a patent for "Hybridization-ligation assays for the detection of specific nucleic acid." This patent describes a new method for conducting gene probe assays. The preferred technique involves using a gene amplification method, such as PCR, to multiply the gene sequence of interest. Additionally, it employs a hybridization-ligation detection methodology, where probes hybridized to the target sequence allow for separation and detection. This method may utilize probes containing a combination of magnetic particles and acridinium esters to determine the presence of a specific sequence.

Career Highlights

Throughout his career, John has worked with Chiron Diagnostics Corporation, where he has applied his expertise in molecular diagnostics. His work has contributed to advancements in the detection of genetic material, which is crucial for various applications in healthcare and research.

Collaborations

John C Arruda has collaborated with Richard A Martinelli, further enhancing the innovative work being done in the field of nucleic acid detection.

Conclusion

John C Arruda's contributions to the field of molecular biology, particularly through his patent on hybridization-ligation assays, demonstrate his commitment to advancing scientific knowledge and technology. His work continues to impact the way specific nucleic acids are detected, paving the way for future innovations in diagnostics.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…